In summary, since TACC3 overexpression seems to indicate an aggressive phenotype, it is tempting to speculate that TACC3 would be a potential therapeutic target or a prognostic factor that could be used to predict therapeutic modalities and outcomes in bladder cancer. Here, TACC3 is linked to urinary bladder carcinoma.